Cipher Pharmaceuticals Inc.
CPHRF
$9.01
$0.06040.68%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -56.32% | -95.97% | -2.47% | 87.47% | -61.10% |
| Total Depreciation and Amortization | 453.48% | 615.61% | -14.62% | -15.74% | -19.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -631.55% | 100.61% | 143.48% | -354.82% | 105.28% |
| Change in Net Operating Assets | 228.51% | -112.75% | 1,421.50% | -233.36% | -51.83% |
| Cash from Operations | 267.60% | -66.47% | 111.30% | -47.82% | 77.07% |
| Capital Expenditure | 95.14% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 95.14% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -94.44% | -265.52% | -38.10% | -12.00% | -50.00% |
| Issuance of Common Stock | -92.35% | -92.54% | -27.27% | 63.49% | 335.56% |
| Repurchase of Common Stock | 100.00% | 100.00% | 100.00% | -144.44% | -2,340.67% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 97.90% | 146,418.52% | 97.93% | -197.06% | -2,528.19% |
| Foreign Exchange rate Adjustments | -213.27% | 126.53% | -199.52% | -327.50% | 123.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 467.67% | -769.10% | 106.22% | -53.04% | -266.37% |